admin | SentrX

EyeGate Pharma Announces Positive Results in Punctate Epitheliopathy Study

November 26, 2019
Posted by admin

25 Nov

EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial results for the three-month period

Uncategorized

EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with Sentrx Animal Care

November 27, 2019
Posted by admin

25 Nov

EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating